| Financial Year |
March 31 2023 |
| Monetary Funds |
192,265,249.27 |
| Held-for-trading Financial Assets |
15,878,862.60 |
| Notes Receivable |
33,074,614.36 |
| Accounts Receivable |
1,983,227,430.56 |
| Advances to Suppliers |
146,732,546.73 |
| Other Receivables |
92,024,918.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
796,537,789.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
110,614,513.29 |
| Total Current Assets |
4,628,884,341.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,259,368.17 |
| Investment Properties |
153,994,887.34 |
| Fixed Assetes |
504,037,813.67 |
| Under-construction Projects |
58,726,654.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,625,542.55 |
| R&D expenses |
357,212.14 |
| Goodwill |
183,520,730.57 |
| Long-Term Deferred and Prepaid Expenses |
12,830,433.49 |
| Deferred Income Tax Assets |
6,971,488.03 |
| Other Non-Current Assets |
127,992,791.07 |
| Sub-Total of Non-Current Assets |
1,152,395,179.26 |
| Total Assets |
5,781,279,520.76 |
| Short-Term Loans |
896,849,091.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,584,727.98 |
| Accounts Payable |
3,900,468,278.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,550,023.98 |
| Taxes Payable |
17,674,665.83 |
| Interest Payable |
125,291.67 |
| Dividend Payable |
-- |
| Other payables |
101,482,255.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,355,057.18 |
| Other Current Liabilities |
413,423,552.34 |
| Sub-Total of Current Liabilities |
5,513,309,533.30 |
| Long-term Loans |
32,282,738.95 |
| Bonds Payable |
348,465,727.88 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,143,639.36 |
| Deferred Income Tax Liabilities |
1,579,879.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
401,519,905.55 |
| Total Liabilities |
5,914,829,438.85 |
| Paid-In Capital(Or Share Stock) |
580,070,382.00 |
| Capital Surplus |
607,404,226.84 |
| Surplus Reserve |
75,845,260.64 |
| LESS:Treasury Stock |
70,000,801.96 |
| Undistributed Profits |
-1,482,435,467.17 |
| Minority Stockholder's Interest |
108,755,688.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-242,305,607.02 |
| Owner's Equity（Stockholder's Equity） |
-133,549,918.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,781,279,520.76 |
